High protein supplement
US8362297B2 · kind B2 · utility
2Cited by
26References
12Claims
0Family size
Inventor
Key dates
| Filing date | Jun 20, 2011 |
| Grant date | Jan 29, 2013 |
| Priority date | — |
| Expiry date | Jun 20, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to high protein dietary supplements for treating various symptoms and diseases associated with protein deficiency including weight gain, obesity, catabolic diseases, fibromyalgia, anxiety reactions, posttraumatic stress and chronic fatigue syndrome. Embodiments of dietary supplements comprise combinations of proteins, essential and semi-essential amino acids including L-Lysine, L-Arginine, and/or L-Histidine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.